Neutralizing antibodies against the V3 loop of human immunodeficiency virus type 1 gp120 block the CD4-dependent and -independent binding of virus to cells

Journal of Virology

Volumn 71, Issue 11, 1997, Pages 8289-8298

  Valenzuela, Agustín ^a,b   Blanco, Julià ^a   Krust, Bernard ^a   Franco, Rafael ^b   Hovanessian, Ara G ^a,c  

^a CNRS   (France)

^b UNIVERSITY OF BARCELONA   (Spain)

^c INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 120; NEUTRALIZING ANTIBODY;

ARTICLE; BINDING AFFINITY; CELL ADHESION; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; VIRUS MORPHOLOGY; VIRUS SHEDDING; VIRUS VIRULENCE;

EID: 0030843486     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.11.8289-8298.1997     Document Type: Article

References (57)

1. Barbas, C. F., III, E. Björling, F. Chiodi, N. Dunlop, D. Cababa, T. M. Jones, S. L. Zebedee, M. A. A. Persson, P. L. Nara, E. Norrby, and D. R. Burton. 1992. Recombinant human Fab fragments neutralize human type I immunodeficiency virus in vitro. Proc. Natl. Acad. Sci. USA 89:9339-9343.
2. Blank, U., B. Boitel, D. Mège, M. Ermonval, and O. Acuto. 1993. Analysis of tetanus toxin peptide/DR recognition by human T cell receptors reconstituted into a murine cell hybridoma. Eur. J. Immunol. 23:3057-3065.
3. Bour, S., R. Geleziunas, and M. A. Wainberg. 1995. The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection. Microbiol. Rev. 59:63-93.
4. Burton, D. R., C. F. Barbas, M. A. A. Persson, S. Koenig, R. M. Chanock, and R. A. Larner. 1991. A large array of human monoclonal antibodies to HIV-1 from combinatorial libraries of assymptomatic seropositive individuals. Proc. Natl. Acad. Sci. USA 88:10134-10137.
5. + cells. Science 262:2045-2050.
6. Callebaut, C., E. Jacotot, G. Guichard, B. Krust, M. A. Rey-Cuillé, D. Cointe, N. Benkirane, J. Blanco, S. Muller, J. P. Briand, and A. G. Hovanessian. 1996. Inhibition of HIV infection by pseudopeptides blocking viral envelope glycoprotein-mediated membrane fusion and cell death. Virology 218:181-192.
7. Callebaut, C., E. Jacotot, B. Krust, G. Guichard, J. Blanco, A. Valenzuela, J. Svab, S. Muller, J. P. Briand, and A. G. Hovanessian. 1997. Pseudopeptide TASP inhibitors of HIV infection block viral entry by binding to a 95 kDa cell surface protein. J. Biol. Chem. 272:7159-7166.
8. Callebaut, C., J. Blanco, B. Krust, G. Guichard, E. Jacotot, J. Svab, S. Muller, J. P. Briand, and A. G. Hovanessian. Submitted for publication.
9. Chin, L. T., M. Duenas, M. Levi, J. Hinkula, B. Wahren, and C. A. K. Borrebaeck. 1995. Molecular characterization of a human anti-HIV 1 monoclonal antibody revealed a CD26-related motif in CDR2. Immunol. Lett. 44:25-30.
10. Choe, H., M. Farzan, Y. Sun, N. Sullivan, B. Rollins, P. D. Ponath, L. Wu, C. R. Mackay, G. LaRosa, M. Newman, N. Gerard, and J. Sodroski. 1996. The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85:1135.
11. Cordell, J., J. P. Moore, C. J. Dean, P. J. Klasse, R. A. Weiss, and J. A. McKeating. 1991. Rat monoclonal antibodies to nonoverlapping epitopes of human immunodeficiency virus type 1 gp120 block CD4 binding in vitro. Virology 185:72-79.
12. Dagleish, A. G., P. C. L. Beverley, P. R. Clapham, D. H. Crawford, M. F. Greaves, and R. A. Weiss. 1984. The CD4 (T4) receptor antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312: 763-766.
13. Demaria, S., and Y. Bushkin. 1996. Soluble CD4 induces the binding of human immunodeficiency virus type I to cells via the V3 loop of glycoprotein gp120 and specific sites in glycoprotein 41. AIDS Res. Hum. Retroviruses 12:281-290.
14. Deng, H., R. Liu, W. Ellmeier, S. Choe, D. Unutmaz, M. Burkhart, P. Di Marzio, S. Marmon, R. E. Sutton, C. M. Hill, C. B. Davis, S. C. Peiper, T. J. Schall, D. R. Littman, and N. R. Landau. 1996. Identification of a major co-receptor for primary isolates of HIV-1. Nature 381:661-664.
15. Doranz, B., J. Rucker, Y. Yi, R. J. Smyth, M. Samson, S. C. Peiper, N. Parmentier, R. G. Collman, and R. W. Doms. 1996. A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 85:1149.
16. + cells is mediated by the chemokine receptor CC-CKR-5. Nature 381:667-670.
17. D'Souza, M. P., and V. A. Harden. 1996. Chemokines and HIV-1 second receptors. Nat. Med. 2:1293-1300.
18. Feng, Y., C. C. Broder, P. E. Kennedy, and E. A. Berger. 1996. HIV-1 entry cofactor. Functional cloning of a seven-transmembrane G protein-coupled receptor. Science 272:872-876.
19. Harouse, J. M., S. Bhat, S. L. Spitalnick, M. Laughlin, K. Stefano, D. H. Silbergberg, and F. Gonzalez-Scarano. 1991. Inhibition of entry of HIV-1 in neural cell lines by antibodies against galactosyl ceramide. Science 253:320-323.
20. Harouse, J. M., R. G. Collman, and F. Gonzalez-Scarano. 1995. Human immunodeficiency virus type 1 infection of SK-N-MC cells: domains of gp120 involved in entry into a CD4-negative, galactosyl ceramide/3′-sulfo-galactosyl ceramide-positive cell line. J. Virol. 69:7383-7390.
21. Harrop, H. A., D. R. Coombe, and C. C. Rider. 1994. Heparin specifically inhibits binding of V3 loop antibodies to HIV-1 gp120, an effect potentiated by CD4 binding. AIDS 8:183-192.
22. Hildreth, J. E. K., and R. J. Orentas. 1989. Involvement of a leukocyte adhesion receptor (LFA-1) in HIV-induced syncytium formation. Science 244:1075-1078.
23. + T cells. Virology 223:318-330.
24. Klatzman, D., E. Champagne, S. Chamaret, J. Gruest, D. Guetard, T. Hercend, J. C. Gluckman, and L. Montagnier. 1984. T lymphocyte T4 molecule behaves as the receptor for the AIDS virus. Nature 312:767-768.
25. Krust, B., C. Callebaut, and A. G. Hovanessian. 1993. Inhibition of entry of HIV into cells by poly(A).poly(U). AIDS Res. Hum. Retroviruses 9:1087-1090.
26. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
27. Laman, J. D., M. M. Schellekens, Y. F. Abacioglu, G. K. Lewis, M. Tersmette, J. P. M. Langedick, E. Claassen, and W. J. A. Boersma. 1992. Variant-specific monoclonal and group-specific polyclonal human immunodeficiency virus type 1 neutralizing antibodies raised with synthetic peptides from the gp120 third hypervariable domain. J. Virol. 66:1823-1831.
28. Lapham, C. K., J. Ouyang, B. Chandrasekhar, N. Y. Nguyen, S. Dimitrov, and H. Golding. 1996. Evidence for cell-surface association between fusin and the CD4-gp120 complex in human cell lines. Science 274:602-605.
29. Laurent, A. G., B. Krust, J. Galabru, J. Svab, and A. G. Hovanessian. 1985. Monoclonal antibodies to interferon induced 68,000-Mr protein and their use for the detection of double-stranded RNA dependent protein kinase in human cells. Proc. Natl. Acad. Sci. USA 82:4341-4345.
30. Laurent-Crawford, A. G., and A. G. Hovanessian. 1993. The cytopathic effect of human immunodeficiency virus is independent of high levels of unintegrated viral DNA accumulated in response to superinfection of cells. J. Gen. Virol. 74:2619.
31. Linsley, P. S., J. A. Ledbetter, E. Kinney-Thomas, and S.-L. Hu. 1988. Effects of anti-gp120 monoclonal antibodies on CD4 receptor binding by the Env protein of human immunodeficiency virus type 1. J. Virol. 62:3695-3702.
32. McDougal, J. S., M. S. Kennedy, S. L. Orloff, J. K. A. Nicholson, and T. S. Spira. 1996. Mechanisms of human immunodeficiency virus type 1 (HIV-1) neutralization: irreversible inactivation of infectivity by anti-HIV-1 antibody. J. Virol. 70:5236-5245.
33. McInerney, T. L., L. McLain, S. J. Armstrong, and N. J. Dimmock. 1997. A human IgG1 (b12) specific for the CD4 binding site of HIV-1 neutralizes by inhibiting the virus fusion entry process, but b12 Fab neutralizes by inhibiting a post fusion event. Virology 233:313-326.
34. McKeating, J. A., J. Cordell, C. J. Dean, and P. Balfe. 1992. Synergistic interaction between ligands binding to the CD4 binding site and V3 domain of human immunodeficiency virus type 1 gp120. Virology 191:732-742.
35. McKeating, J. A., M. Thali, C. Furman, S. Karwowska, M. K. Gorny, J. Cordell, S. Zolla-Pazner, J. Sodroski, and R. A. Weiss. 1992. Amino acid residues of the human immunodeficiency virus type 1 gp120 critical for the binding of rat and human neutralizing antibodies that block the gp120-sCD4 interaction. Virology 190:134-142.
36. Moore, J. P., and P. L. Nara. 1991. The role of the V3 loop of gp120 in HIV infection. AIDS 5:S21-S33.
37. Moore, J. P., and D. D. Ho. 1995. HIV neutralization: the consequence of viral adaptation to growth on transformed T cells. AIDS. 9(Suppl. A):S117-S136.
38. Moore, J. P., B. A. Jameson, R. A. Weiss, and Q. J. Sattentau. 1993. The HIV-cell fusion reaction, p. 233-289 In J. Bentz (ed.), Viral fusion mechanisms - 1993. CRC Press, Boca Raton, Fla.
39. 2, binds human immunodeficiency virus type 1 gp120 and cleaves the third-variable-domain loop of gp120. Neutralizing antibodies of human immunodeficiency virus type 1 inhibit cleavage of gp120. Eur. J. Biochem. 237:64-70.
40. Oberlin, E., A. Amara, F. Bachelerie, C. Bessia, J. L. Virelizier, F. Arenzana-Seisdedos, O. Schwartz, J. M. Heard, I. Clarck-Lewis, D. F. Legler, M. Loetscher, M. Baggiolini, and B. Moser. 1996. The CXC chemokine, stromal cell derived factor (SDF-1), is the ligand for LESTR/fusin and prevents infection by lymphocyte-tropic HIV-1 syncytium-inducing strains. Nature 382:833-837
41. Olshevsky, U., E. Helseth, C. Furman, J. Li, W. Haseltine, and J. Sodroski. 1990. Identification of individual human immunoceficiency virus type 1 gp120 amino acids important for CD4 binding. J. Virol. 64:5701-5707.
42. Oravecz, T., G. Roderiquez, J. Koffi, J. Wang, M. Ditto, D. C. Bou-Habib, P. Lusso, and M. A. Norcross. 1995. CD26 expression correlates with entry, replication and cytopathicity of monocytotropic HIV-1 strains in a T-cell line. Nat. Med. 1:919-926.
43. Oravecz, T., M. Pall, and M. A. Norcross. 1996. β-Chemokine inhibition of monocytotropic HIV-1 infection. J. Immunol. 157:1329-1332.
44. Patel, M., M. Yanagishita, D. C. Bou-Habib, H. Mostowski, and M. A. Norcross. 1993. Cell-surface heparan sulfate proteoglycan mediates HIV-1 infection of T-cell lines. AIDS Res. Hum. Retroviruses 9:167-174.
45. Pinter, A., W. Honnen, and S. A. Tilley. 1993. Conformational changes affecting the V3 and CD4-binding domains of human immunodeficiency virus type 1 gp120 associated with Env processing and with binding of ligands to these sites. J. Virol. 67:5692-5697.
46. Poignard, P., T. Fouts, D. Naniche, J. P. Moore, and Q. J. Sattentau. 1996. Neutralizing antibodies to human immunodeficiency virus type-1 gp120 induce envelope glycoprotein subunit dissociation. J. Exp. Med. 183:473-484.
47. Roderiquez, G., T. Oravecz, M. Yanagishita, D. C. Bou-Habib, H. Mostowski, and M. A. Norcross. 1995. Mediation of human immunodeficiency virus type 1 binding by interaction of cell surface haparan sulfate proteoglycans with the V3 region of envelope gp120-gp41. J. Virol. 69:2233-2239.
48. Sattentau, Q. J. 1996. Neutralization of HIV-1 by antibody. Curr. Opin. Immunol. 8:540-545.
49. Sattentau, Q. J. Personal communication.
50. Sommerfelt, M. A., and B. Asjo. 1995. Intercellular adhesion molecule 3, a candidate for human immunodeficiency virus type 1 co-receptor in lymphoid and monocytoid cells. J. Gen. Virol. 76:1345-1352.
51. Starcich, B. R., B. H. Hahn, G. M. Shaw, P. D. McNeely, S. Modrow, H. Wolf, W. P. Parks, S. F. Josephs, R. C. Gallo, and F. Wong-Staal. 1986. Identification and characterization of conserved and variable regions in the envelope of HTLV-III/LAV, the retrovirus of AIDS. Cell 45:637-648.
52. Thomas, E. K., J. N. Weber, J. McClure, P. R. Clapham, M. C. Singhal, M. K. Shriver, and R. A. Weiss. 1988. Neutralizing monoclonal antibodies to the AIDS virus. AIDS 2:25-29.
53. Trkola, A., T. Dragic, J. Arthos, J. M. Binley, W. C. Olson, G. P. Allaway, C. Cheng-Mayer, J. Robinson, P. J. Maddon, and J. P. Moore. 1996. CD4-dependent antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5. Nature 384:184-187.
54. Valenzuela, A., J. Blanco, C. Callebaut, E. Jacotot, C. Lluis, A. G. Hovanessian, and R. Franco. 1997. Adenosine deaminase binding to human CD26 is inhibited bv HIV-1 envelope gp120 and viral particles. J. Immunol. 158: 3721-3729.
55. Wiley, R. L., R. A. Rutledge, S. Dias, T. Folks, T. S. Theodore, C. E. Buckler, and M. A. Martin. 1986. Identification of conserved and divergent domains within the envelope gene of the immunodeficiency syndrome virus. Proc. Natl. Acad. Sci. USA 83:5038-5042.
56. Wu, L., N. P. Gerard, R. Wyatt, H. Choe, C. Parolin, N. Ruffing, A. Borsetti, A. A. Cardoso, E. Desjardin, W. Newman, C. Gerard, and J. Sodroski. 1996. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature 384:179-183.
57. Yahi, N., J. M. Sabatier, F. Gonzalez-Scarano, and J. Fantini. 1995. Synthetic multimeric peptides derived from the principal neutralization domain (V3 loop) of human immunodeficiency virus type 1 (HIV-1) gp120 bind to galactosyl ceramide and block HIV-1 infection in a human CD4-negative mucosal epithelial cell line. J. Virol. 69:320-325.